Consistent with the IHI’s policy, faculty for this program are expected to disclose, at the beginning of their presentation(s), any economic or other personal interests that create, or may be perceived as creating, a conflict related to the material discussed. The intent of this disclosure is not to prevent a speaker with a significant financial or other relationship from making a presentation, but rather to provide participants with information on which they can make their own judgments.

Unless otherwise noted below, each presenter provided full disclosure information, does not intend to discuss an unapproved/investigative use of a commercial product/device, and has no significant financial relationship(s) to disclose. If unapproved uses of products are discussed, presenters are expected to disclose this to participants.

James B. Conway, MS, Senior Vice President, Institute for Healthcare Improvement (IHI), was an IHI Senior Fellow from 2005-2006. From 1995-2005, he served as Executive Vice President and COO of Dana-Farber Cancer Institute (DFCI). Prior to joining DFCI, he had a 27-year career at Children's Hospital, Boston, in radiology administration, finance, and as assistant hospital director for patient care services. His areas of expertise include governance and executive leadership, patient safety, change management, and patient- and family-centered care. Mr. Conway serves on several boards, is an Officer for the Massachusetts Coalition for the Prevention of Medical Errors, and a Distinguished Advisor to the National Patient Safety Foundation. He is a member of the Institute of Medicine Committee on Identifying and Preventing Medication Errors; the Commonwealth of Massachusetts Quality and Cost Council; the Clinical Issues Advisory Council of the Massachusetts Hospital Association; and a past member of The Joint Commission Sentinel Event Alert Advisory Group.